Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.3150 (-0.19%) ($5.3150 - $5.3150) on Fri. Jul. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.13% (three month average) | RSI | 21 | Latest Price | $5.3150(-0.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.7% a day on average for past five trading days. | Weekly Trend | AUTL declines -6.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(54%) ARKG(49%) ARKK(48%) IWO(48%) IBUY(47%) | Factors Impacting AUTL price | AUTL will decline at least -3.065% in a week (0% probabilities). VIXM(-30%) VXX(-28%) SHY(-19%) TLT(-16%) XLU(-14%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.065% (StdDev 6.13%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.76(-302.45%) | Resistance Level | $6.04 | 5 Day Moving Average | $5.39(-1.39%) | 10 Day Moving Average | $5.66(-6.1%) | 20 Day Moving Average | $6.04(-12%) | To recent high | -33.1% | To recent low | 6.1% | Market Cap | $278m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |